Loading...

UCB SA

UCBJY•PNK
Healthcare
Biotechnology
$131.58
$-0.64(-0.48%)
U.S. Market opens in 2h 6m

UCB SA (UCBJY) Stock Overview

Explore UCB SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap50.1B
P/E Ratio27.64
EPS (TTM)$4.70
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$125.82
3 Months$158.02
1 Year Target$179.52

UCBJY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of UCB SA (UCBJY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 28.45, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $179.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.64 and a market capitalization of 50.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.66%
5-Day Change
-7.25%
1-Month Change
-9.17%
3-Month Change
-13.55%
6-Month Change
-3.25%
Year-to-Date (YTD) Change
-6.02%
1-Year Change
47.40%
3-Year Change
181.20%
5-Year Change
181.69%
All-Time (Max) Change
775.67%

Contact Information

https://www.ucb.com
32 2 559 99 99
Allée de la Recherche, 60, Brussels, NaN, 1070

Company Facts

9,052 Employees
IPO DateAug 3, 2012
CountryBE
Actively Trading

Frequently Asked Questions